enGene Therapeutics Inc. ENGN
1.75 USD +0.07 (+4.17%)
At closeNov 6, 2026, 4:00 PM EST
1.75 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
1.63 Day range 1.78
1.44 52-week range 12.17
- YTD
- -80.62%
- 1 year
- -70.93%
Latest period ending Oct 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Oct 31, 2025 | FY 2024 Oct 31, 2024 | FY 2023 Oct 31, 2023 | FY 2022 Oct 31, 2022 | FY 2021 Oct 31, 2021 |
|---|---|---|---|---|---|
| -123.17M | -62.30M | -26.06M | -19.43M | -15.87M | |
| -117.30M | -55.14M | -99.92M | -24.46M | -23.44M | |
| -2.29 | -1.46 | -151.22 | -44.30 | -6.25 |
Balance sheet
| Fiscal year | FY 2025 Oct 31, 2025 | FY 2024 Oct 31, 2024 | FY 2023 Oct 31, 2023 | FY 2022 Oct 31, 2022 | FY 2021 Oct 31, 2021 |
|---|---|---|---|---|---|
| 50.15M | 173.00M | 81.52M | 20.43M | 11.10M | |
| 221.47M | 311.17M | 86.96M | 23.91M | 15.03M | |
| 53.76M | 38.56M | 14.47M | 47.41M | 15.35M | |
| 31.80M | 25.02M | 9.78M | 28.32M | 3.55M | |
| 167.71M | 272.61M | 72.49M | -76.61M | -53.44M |
Cash flow
| Fiscal year | FY 2025 Oct 31, 2025 | FY 2024 Oct 31, 2024 | FY 2023 Oct 31, 2023 | FY 2022 Oct 31, 2022 | FY 2021 Oct 31, 2021 |
|---|---|---|---|---|---|
| -99.24M | -48.28M | -24.74M | -17.59M | -15.98M | |
| -25.14M | -125.95M | -318.00K | -153.00K | -247.00K | |
| 1.52M | 265.72M | 86.15M | 27.97M | 22.52M | |
| -1.49M | -925.00K | -318.00K | -153.00K | -247.00K | |
| -122.85M | 91.48M | 61.09M | 9.42M | 6.39M |